Integrated Programs Track Record
Rapidly advance your molecules from hit-to-lead
60+ integrated
Fully integrated programs since 2007
Majority on first-in-class targets
20+ large pharma
From 2007, we have worked with 20+
large pharma on integrated programs
Team & Process
Our most experienced science teams & project management connect all aspects of drug discovery through development
Accelerate Timelines
- Rare Disease: Hit-to-lead > P1 Trial (saved 2 years)
- Oncology : Preclinical > PII Trial (saved 2 years)
- Inflammation: Hit-to-lead > PDC (11 months)
- Typical time savings 25-35% of business plan
Create Value
- Inflammation: Partner outlicensed asset $10+ MM
- Epigenetic: Partner closed $16+ MM round (pharma)
- Multiple virtual & midcap partners acquired by big pharma with assets valued heavily in deals